BRIP1 and breast carcinoma: Overall, studies have estimated that there is a 1.2- to 3.2-fold higher risk for developing breast cancer in patients <40 years of age with identified BRIP1 mutations compared to non-carriers, and that 1% of patients with early-onset or familial breast cancer carried a deleterious BRIP1 mutation [152,153,156].